We found that colon cancer tissues that had BRAF but not KRAS mutations demonstrated significantly lower concentrations of total ERK, AKT, cyclin d and activated ERK and AKT as compared to Wt. This evidence concerns the gene BRAF and malignant colon neoplasm.